NEXTBIOMEDICAL (389650.KQ) — Stock Score Summary

NEXTBIOMEDICAL (389650.KQ) has a MoatMap StockRank of 20/100 based on Quality (47/100), Value (38/100), and Momentum (20/100) factor scores. The current signal is STRONG SELL.

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization.

Key Financial Metrics

Price$26.73
Market Cap$217M
P/E (Forward)42.62
Price/Book6.86
Return on Equity-0.1%
Return on Invested Capital0.1%
Debt/Equity15.17
Gross Margin70.1%
Operating Margin-28.9%
Revenue Growth9.2%
Free Cash Flow$-2K

NEXTBIOMEDICAL operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is NEXTBIOMEDICAL’s (389650.KQ) StockRank?
MoatMap’s StockRank for NEXTBIOMEDICAL (389650.KQ) is 20/100, with a Strong Sell signal. It is a composite of Quality (47), Value (38), and Momentum (20) factor ranks across MoatMap’s 19,000+ stock universe.
Does NEXTBIOMEDICAL have an economic moat?
NEXTBIOMEDICAL (389650.KQ) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is NEXTBIOMEDICAL a buy, hold, or sell?
MoatMap’s current signal for NEXTBIOMEDICAL (389650.KQ) is Strong Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is NEXTBIOMEDICAL in?
NEXTBIOMEDICAL (389650.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks389650.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock